250 related articles for article (PubMed ID: 8670088)
21. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
Paul A; Nadimpally KC; Mondal T; Thalluri K; Mandal B
Chem Commun (Camb); 2015 Feb; 51(12):2245-8. PubMed ID: 25514992
[TBL] [Abstract][Full Text] [Related]
23. 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40).
LeVine H
Arch Biochem Biophys; 2002 Aug; 404(1):106-15. PubMed ID: 12127075
[TBL] [Abstract][Full Text] [Related]
24. Identification of peptide products from enzymatic degradation of amyloid beta.
Rogeberg M; Furlund CB; Moe MK; Fladby T
Biochimie; 2014 Oct; 105():216-20. PubMed ID: 25010651
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein J and Alzheimer's amyloid beta solubility.
Matsubara E; Soto C; Governale S; Frangione B; Ghiso J
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):671-9. PubMed ID: 8687416
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
Soto C; Kindy MS; Baumann M; Frangione B
Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
[TBL] [Abstract][Full Text] [Related]
27. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
28. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
29. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
Jarrett JT; Berger EP; Lansbury PT
Biochemistry; 1993 May; 32(18):4693-7. PubMed ID: 8490014
[TBL] [Abstract][Full Text] [Related]
30. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
31. The C-terminus of the beta protein is critical in amyloidogenesis.
Jarrett JT; Berger EP; Lansbury PT
Ann N Y Acad Sci; 1993 Sep; 695():144-8. PubMed ID: 8239273
[TBL] [Abstract][Full Text] [Related]
32. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
33. Using chiral peptide substitutions to probe the structure function relationship of a key residue of Aβ42.
Warner CJ; Dutta S; Foley AR; Chen E; Kliger DS; Raskatov JA
Chirality; 2017 Jan; 29(1):5-9. PubMed ID: 27933649
[TBL] [Abstract][Full Text] [Related]
34. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
35. Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.
Sugiki T; Utsunomiya-Tate N
Biochem Biophys Res Commun; 2013 Nov; 441(2):493-8. PubMed ID: 24383085
[TBL] [Abstract][Full Text] [Related]
36. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.
Barrow CJ; Zagorski MG
Science; 1991 Jul; 253(5016):179-82. PubMed ID: 1853202
[TBL] [Abstract][Full Text] [Related]
37. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.
Tomaselli S; Esposito V; Vangone P; van Nuland NA; Bonvin AM; Guerrini R; Tancredi T; Temussi PA; Picone D
Chembiochem; 2006 Feb; 7(2):257-67. PubMed ID: 16444756
[TBL] [Abstract][Full Text] [Related]
38. Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates.
Fasman GD; Perczel A; Moore CD
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):369-71. PubMed ID: 7831292
[TBL] [Abstract][Full Text] [Related]
39. Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).
Terzi E; Hölzemann G; Seelig J
Biochemistry; 1994 Feb; 33(6):1345-50. PubMed ID: 8312252
[TBL] [Abstract][Full Text] [Related]
40. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
Ahmad A; Muzaffar M; Ingram VM
Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
